It’s official: Meet 4 of the country’s most impressive healthcare startups
A quartet of companies on Wednesday were selected among the 44 companies that presented at MedCity INVEST, MedCity News' healthcare investing conference.
One way the next generation of angel investors is acting more like VCs (and it’s actually a good thing)
"Traditionally we waited for folks to come to us."
The Human Algorithm: What AI Can’t Replace in Pharma Engagement
At a time when AI is reshaping pharma, Reverba Global CEO Cheryl Lubbert explained in an interview why empathy, context, and ethics still require a human touch.
Morning Read: Get ready to hear a lot about Obamacare 2.0
Also, read about Sequenom's very important patent fight, a petition for a unique patient ID, and a gentle critique on the Cancer Moonshot.
Morning Read: Affymetrix rejects the latest takeover bid meant to derail Thermo Fisher’s offer
Also, the latest hospital cyber attack (a ransomware attack), Zika gets political, a poll on the best kind of HIMSS keynotes, and the Valeant obituaries are rolling in.
Morning Read: I know what YOU think of the Express Scripts drug report. But what will the candidates think?
Also, Oscar grabs a Google VP as its CTO, new telemedicine reimbursements and a new policy concept: a $3 billion federal prize for AIDS breakthroughs.
Morning Read: Healthcare’s integration into SXSW (2016 edition) is underway
Also, a preview of Valeant's "watershed" moment, do-it-yourself CRISPR and health insurance experiments that are gaining traction.
What Are Healthcare Organizations Getting Wrong about Email Security?
A new report by Paubox calls for healthcare IT leaders to dispose of outdated assumptions about email security and address the challenges of evolving cybersecurity threats.
Morning Read: More bad Theranos news, will family caregivers get their own tax credit?
Also, previews of the CRISPR patent fight and Toshiba medical auction happening this week.
Morning Read: Why Nancy Reagan mattered to medical innovation
Also, HIMSS keynote strategy mocked, ACOs continues to be pummeled, and a new European initiative to speed up approval of innovative drugs.
HIMSS Day 5 Buzz: It’s all over – and now the work begins
A simple question (followed by a shameless plug): What will we see from HIMSS culminate in real action the rest of the year? An embrace of secure patient portals? Interoperability policies turned into action? Meaningful progress on providers ready for pay-for-value? Better EMRs? So many discussions at HIMSS. To get a better gauge on what […]
Morning Read: Digital health investing in February, Obamacare hits an important milestone early
Also, more details on the Trump healthcare plan and a ridiculous wellness incentive.
Solving Healthcare’s Provider Data Problem Starts with Interoperability
Break down the silos. Take control of your provider data.
MedHeads: Looking back at what was (and wasn’t) said at HIMSS16
Neil Versel and guests break down the week of HIMSS16.
#HIMSS16 Day 4 Buzz: Let’s rank the big issues discussed at HIMSS
Also, getting real on HIMSS16 turnout, a hard look at medical scribes and Mitt Romney makes an appearance.
Morning Read: Let’s start paying attention to Donald Trump’s healthcare plans
Also, Google gets into the fight for Zika, a new cancer startup using "PARP" inhibitors, and New York claims some insurance companies are rationing care around Hep C drugs.
#HIMSS16 Day 3 Buzz: Is there a Donald Trump effect with interoperability policy?
Either way, it's put up or shut up time with everything that comes after HIMSS.
#HIMSS16 Day 2 buzz: It starts with interoperability (will it get serious about security?)
Also, HIMSS shows the JP Morgan crowd how its done, HISTalkapalooza highlights and more updates from the show floor.